ScholarLens Back to search
2013•Journal of HepatologyOpen access

1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)

Mark Sulkowski, David Gardiner, Maribel Rodriguez‐Torres, K. Rama Reddy, Tarek Hassanein, Ira M. Jacobson, Erik Lawitz, A. S. F. Lok, Federico Hinestrosa, Paul Joseph Thuluvath, Howard Schwartz, David R. Nelson, Gregory T. Everson, Timothy Eley, Megan Wind‐Rotolo, Shu‐Pang Huang, Min Gao, Fiona McPhee, Dennis J. Hernandez, D. Sherman, Robert G. Hindes, William T. Symonds, Claudio Pasquinelli, Dennis M. Grasela

Open full text 53 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 53 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Boceprevir, Telaprevir, Daclatasvir, Sofosbuvir, Ribavirin, Medicine, Virology, Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC) — Research Paper | ScholarLens